Shaolin Capital Management’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$523K Sell
367,253
-274,466
-43% -$275K 0.03% 283
2026
Q1
$77K Sell
641,719
-50,113
-7% -$11.5K ﹤0.01% 364
2025
Q4
$214K Sell
691,832
-8,168
-1% -$2.68K 0.01% 254
2025
Q3
$203K Hold
700,000
0.01% 205
2025
Q2
$175K Sell
700,000
-30,821
-4% -$6.37K 0.01% 171
2025
Q1
$146K Buy
+730,821
New +$129K 0.01% 100

Other funds holding TDACW

Shaolin Capital Management's TDACW Position: Q2 2026 in Review

Shaolin Capital Management reduced its Translational Development Acquisition Corp Warrants (TDACW) stake by 43% in Q2 2026, selling an estimated $275K and leaving 367,253 shares worth $523K. The position accounts for 0.03% of the portfolio, ranked #283.

Shaolin Capital Management first reported a position in TDACW in Q1 2025 and has held it in 6 quarters since. 28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.

  • Shaolin Capital Management held 367,253 shares of Translational Development Acquisition Corp Warrants worth $523K as of Q2 2026.
  • Shaolin Capital Management sold 274,466 Translational Development Acquisition Corp Warrants shares in Q2 2026, an estimated $275K.
  • Translational Development Acquisition Corp Warrants made up 0.03% of Shaolin Capital Management's portfolio in Q2 2026, its #283 holding.
  • Shaolin Capital Management first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 6 quarters since.
  • 28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.

Based on Shaolin Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.